(2R,5R)-(+)-2-tert-Butyl-3-methyl-5-benzyl-4-imidazolidinone>97.0%(GC)1g

4-FLUORO-N-METHYL-3-NITROBENZAMIDE, 95.0%, 1g

2-Oxo-6-(trifluoromethyl)-1,2-dihydropyrimidine-5-carboxylic acid, 95+%, 250mg

(3-Chloropyridin-4-yl)methanamine, 98%, 1g

8-Bromo-6-methoxyquinoline, 95.0%, 1g

4-(Trifluoromethyl)benzaldehyde, 98.0%, 100g

Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate, 95.0%, 25g

Butyl(3-phenylpropyl)amine, 75.0%, 1g

2,2-Dimethyl-4-oxo-3,7,10,13,16-pentaoxanonadecan-19-oic acid, 95%, 250mg

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.001 g, 220 g, BCE223-1S (W)

1-(4-Fluorophenyl)-2-thiourea, 95.0%, 100g

4-Hydroxy-3-methoxyphenylacetic Acid>98.0%(T)5g

4-Amino-1-napthalenesulphonic acid sodium salt tetrahydrate, 95%, 500g